Park Ha Biological Technology Co., Ltd. (BYAH)

Market price: $2.26

6 methods not shown

• EV / EBITDA: EBITDA is non-positive — an EBITDA multiple yields no meaningful enterprise value (loss-making at the EBITDA line)
• EV / Revenue: the market prices this company far outside its sector's EV / Revenue range (its own multiple is -1.43 vs a sector band of 0.91–2.77) — a sector-average bar would be misleading here, so it is withheld
• EV / Gross Profit: the market prices this company far outside its sector's EV / Gross Profit range (its own multiple is -1.52 vs a sector band of 2.51–7.37) — a sector-average bar would be misleading here, so it is withheld
• P / E: diluted EPS is non-positive — P/E is not meaningful for a loss-making period
• P / B: the market prices this company far outside its sector's P / B range (its own multiple is 0.04 vs a sector band of 3.03–5.62) — a sector-average bar would be misleading here, so it is withheld
• DCF (FCFF): base unlevered FCF is non-positive (-15,994,007.33) — nothing to discount; a standard FCFF DCF does not apply

Pre-profit company — earnings-based methods not meaningful.

We can't value this company — not enough of the financial data our methods require is available from its SEC filings.